These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 2907559)

  • 1. Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids.
    Moroney MA; Alcaraz MJ; Forder RA; Carey F; Hoult JR
    J Pharm Pharmacol; 1988 Nov; 40(11):787-92. PubMed ID: 2907559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-substituted indazolinones: orally active and selective 5-lipoxygenase inhibitors with anti-inflammatory activity.
    Foster SJ; Bruneau P; Walker ER; McMillan RM
    Br J Pharmacol; 1990 Jan; 99(1):113-8. PubMed ID: 2110012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hypolaetin-8-glucoside and related flavonoids on soybean lipoxygenase and snake venom phospholipase A2.
    Alcaraz MJ; Hoult JR
    Arch Int Pharmacodyn Ther; 1985 Nov; 278(1):4-12. PubMed ID: 3938206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
    Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
    Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actions of flavonoids and the novel anti-inflammatory flavone, hypolaetin-8-glucoside, on prostaglandin biosynthesis and inactivation.
    Alcaraz MJ; Hoult JR
    Biochem Pharmacol; 1985 Jul; 34(14):2477-82. PubMed ID: 3839399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of leukocyte eicosanoid generation and radical scavenging activity by gnaphalin, a lipophilic flavonol isolated from Helichrysum picardii.
    de la Puerta R; Forder RA; Hoult JR
    Planta Med; 1999 Aug; 65(6):507-11. PubMed ID: 10483368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple procedure for measuring the pharmacodynamics and analgesic potential of lipoxygenase inhibitors.
    Carey F; Haworth D; Edmonds AE; Forder RA
    J Pharmacol Methods; 1988 Dec; 20(4):347-56. PubMed ID: 3145369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SK&F 86002: a structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid.
    Griswold DE; Marshall PJ; Webb EF; Godfrey R; Newton J; DiMartino MJ; Sarau HM; Gleason JG; Poste G; Hanna N
    Biochem Pharmacol; 1987 Oct; 36(20):3463-70. PubMed ID: 2823821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability.
    Laughton MJ; Evans PJ; Moroney MA; Hoult JR; Halliwell B
    Biochem Pharmacol; 1991 Oct; 42(9):1673-81. PubMed ID: 1656994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are tolfenamic acid and tenidap dual inhibitors of 5-lipoxygenase and cyclo-oxygenase?
    Proudman KE; McMillan RM
    Agents Actions; 1991 Sep; 34(1-2):121-4. PubMed ID: 1793015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FPL 62064, a topically active 5-lipoxygenase/cyclooxygenase inhibitor.
    Blackham A; Griffiths RJ; Hallam C; Mann J; Mitchell PD; Norris AA; Simpson WT
    Agents Actions; 1990 Jun; 30(3-4):432-42. PubMed ID: 2117338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic enhancement of mitogen responses of human lymphocytes by inhibitors of cyclo-oxygenase and lipoxygenase.
    Blomgren H; Hammarström S; Wasserman J
    Int Arch Allergy Appl Immunol; 1988; 86(1):62-8. PubMed ID: 3131257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of PAF-acether and eicosanoids from guinea-pig alveolar macrophages by FMLP: effect of cyclo-oxygenase and lipoxygenase inhibition.
    Fitzgerald MF; Parente L; Whittle BJ
    Eur J Pharmacol; 1989 May; 164(3):539-46. PubMed ID: 2548873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of sheep platelet arachidonate metabolism by flavonoids from Spanish and Indian medicinal herbs.
    Ferrándiz ML; Nair AG; Alcaraz MJ
    Pharmazie; 1990 Mar; 45(3):206-8. PubMed ID: 2116628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo.
    Tateson JE; Randall RW; Reynolds CH; Jackson WP; Bhattacherjee P; Salmon JA; Garland LG
    Br J Pharmacol; 1988 Jun; 94(2):528-39. PubMed ID: 2840160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative inhibitory potencies of flavonoids on 12-lipoxygenase of fish gill.
    Hsieh RJ; German JB; Kinsella JE
    Lipids; 1988 Apr; 23(4):322-6. PubMed ID: 3398718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of alveolar macrophage 5-lipoxygenase metabolism by auranofin.
    Peters-Golden M; Shelly C
    Biochem Pharmacol; 1989 May; 38(10):1589-95. PubMed ID: 2499339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
    Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo models.
    Ku EC; Raychaudhuri A; Ghai G; Kimble EF; Lee WH; Colombo C; Dotson R; Oglesby TD; Wasley JW
    Biochim Biophys Acta; 1988 Apr; 959(3):332-42. PubMed ID: 2833314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of polymorphonuclear leukocyte 5-lipoxygenase and platelet cyclooxygenase by alpha-(3,5-di-tert-butyl-4-hydroxybenzylidene)-gamma-butyrolacto ne (KME-4), a new anti-inflammatory drug.
    Hidaka T; Takeo K; Hosoe K; Katsumi I; Yamashita T; Watanabe K
    Jpn J Pharmacol; 1985 Jul; 38(3):267-72. PubMed ID: 3932730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.